Page 0004

4

NEWS

Temp-check

tech for feet

Researchers at the Auckland

Bioengineering Institute

have received funding for

a pilot study to trial their

portable temperature-sensing

technology to detect the early

signs of foot complications

among people with Type

2 diabetes. FootSense is a

low-cost device designed for

home-based temperature

monitoring. Research shows

that differences in temperature

between a person's feet

indicate compromises in blood

flow, which can lead to foot

ulcers and, in severe cases,

amputation. To read more

about the technology and the

trial, CLICK HERE.

Insulin

implant

Bioengineers are creating an

insulin-producing implant for

people with Type 1 diabetes using

3D printing and smart biomaterials.

Supported by a grant from JDRF,

Omid Veiseh and Jordan Miller

from Rice University in Houston,

Texas, will use insulin-producing

beta cells made from human stem

cells to create an implant that

senses and regulates blood glucose

levels by responding with the

correct amount of insulin at a given

time. To read more, CLICK HERE.

First Female

Chief Executive

for NHS England

Amanda Pritchard began her role as

the new head of the NHS in England in

August, taking over from Lord Stevens.

Pritchard has been chief operating

officer of NHS England and chief

executive of NHS Improvement since

2019. Pritchard has held several key

roles across the health service, including

running the Guy's and St Thomas' Trust

in London, and as chief executive of

NHS Improvement. She joined the NHS

through the graduate management

training scheme in 1997. As chief operating

officer of NHS England she oversaw the

operational performance of the health

service as well as implementation of

service transformation and improvements

in patient care.

Exenatide for

T2 teens

The FDA has approved an

extended-release version of the

GLP-1 drug exenatide for older

children and teenagers with Type

2 diabetes, Andrew Briskin report

for DiaTribe. BYDUREON BCise is

a once-weekly injection that can

help people manage their glucose

levels together with changes in

their lifestyle, such as diet and

exercise. It has been approved

in the US for adults with Type 2

diabetes for over 15 years old.

Recently published data showed

worryingly high rates and serious

diabetes complications in people

who develop Type 2 diabetes at

a young age, suggesting the need

for aggressive early treatment

and more treatment options. The

approval comes after a clinical trial

- BCB114 - examined the drug's

safety in 10-17-year-olds. Results

showed a 0.4 percentage point

decrease in HbA1C when using

BYDUREON BCise, compared to

a 0.5 percentage point increase

in HbA1C among those taking the

placebo drug.

To read the article in full

CLICK HERE.

AI could save limbs

Results of an AI technology trial at Barts Health NHS Trust shows potential to

prevent thousands of people with diabetes from limb amputation. The study

has already helped identify people at risk of complications, writes Jasmine

Jackson for National Health Executive. The technology has helped to speed up

the process of reviewing data analysed in a project and would now take just a

few weeks to complete from start to finish. Clinicians at the trust said that it

would take over 100 years to go through this process without the AI.

The trust used the technology to scan 14.2 million medical records and

notes to find patients with diabetic foot disease (DFD), discovering 30% more

patients with diabetes and 375% more patients with diabetic foot problems.

This made the process easier for clinicians to schedule earlier treatments to

save feet and limbs from amputation.

Dr Charles Gutteridge, Chief Clinical Information Officer at the trust,

said of the trial, "Attempting this scale of analysis manually would have been

frankly impossible. Theoretically, it would have taken one clinician over a

hundred years to review that volume of documents. So not only does AI

technology help us find patients who we couldn't otherwise find, but it also

saves precious clinical time. This is a first and most important step in being

able to treat many patients earlier than would have been possible using a

manual process to find them and preventing the serious complications that

may result in amputation."

During the subsequent trial phase, the characteristics extracted by the

software in the cohort it identified, along with input from other sources, will

be used to establish whether this process effectively predicts which patients

are most likely to develop the severe complications associated with DFD.

To read more, CLICK HERE.

Index

  1. Free online Desang diabetes magazine, diabetes information
  2. Desang diabetes, magazine diabetes information, Sue Marshall diabetes
  3. Desang diabetes, magazine diabetes information, Sue Marshall diabetes, Snaq
  4. Page 0004
  5. diabetes news, diabetes research news, diabetes information, diabetes kit, diabetes technology
  6. diabetes news, diabetes research news, diabetes information, diabetes kit, diabetes technology
  7. Menarini Glucomen Day CGM
  8. diabetes news, diabetes research news, diabetes information, diabetes kit, diabetes technology
  9. Medtrum A6 Touchcare Nano patch pump and CGM in harmony
  10. diabetes news, diabetes research news, diabetes information, diabetes kit, diabetes technology
  11. diabetes news, NHS diabetes
  12. Page 0012
  13. Dexcom G6 CGM, continuous glucose monitoring
  14. diabetes news, GLP-1s, Diabeloop
  15. Abbott Freestyle Libre 2, Flash Glucose Monitoring, FSL2
  16. Roche Diabetes Care
  17. Roche Diabetes Care
  18. Page 0018
  19. Page 0019
  20. Abbott Freestyle Libre 2, Flash Glucose Monitoring, FSL2
  21. Page 0021
  22. Page 0022
  23. Page 0023
  24. Diabetes technology education from Diabetes Technology Network DTN
  25. Desang diabetes magazine diabetes diet
  26. desang diabetes, diabtes news, diabetes research, diabetes and folic acid, hypo metrics
  27. insulin pump, Dana RS system, artificial pancreas, Advanced Therapeutics UK, CamAPS FX, Dexcom G6
  28. desang diabetes, diabtes news, diabetes research, diabetes and folic acid, hypo metrics
  29. Page 0029
  30. desang diabetes, diabtes news, diabetes research, diabetes and blood pressure
  31. desang diabetes, diabtes news, diabetes research, diabetes and blood pressure
  32. Desang Diabetes Magazine, free online diabetes magazine
  33. Desang Diabetes Magazine, free online diabetes magazine
  34. desang, diabetes diet, diabetic diet, counting carbohydrates, food for
  35. desang, diabetes diet, diabetic diet, counting carbohydrates, food for
  36. desang, diabetes diet, diabetic diet, counting carbohydrates, food for
  37. Medtronic MiniMed 780G System Automated for an easier way to stabilise glucose levels.
  38. Mandira's Kitchen, Desang Diabetes Magazine
  39. BD, Becton Dickinson, injection technique, BD pen needles, BD and Me
  40. Mandira's Kitchen, Desang Diabetes Magazine
  41. Insulet Omnipod DASH insulin pump with insulin pods, podders, Omnipod DASH Personal Diabetes Manager
  42. aking Carbs Count, Carbohydrate counting for diabetes
  43. Making Carbs Count, Carbohydrate counting for diabetes
  44. Making Carbs Count, Carbohydrate counting for diabetes
  45. Desang diabetes kitbags, Desang diabetes diaries
  46. Desang Diabetes Magazine, free diabetes magazine, living with diabetes

Related Issues